城建發展(600266.SH)終止合作開發張儀村棚改項目
格隆匯5月12日丨城建發展(600266.SH)公佈,公司目前在手棚改項目有8個,總投資額超過1000億元。為平衡項目運營,合理控制負債規模,公司擬與北京城建集團有限責任公司(以下簡稱“集團公司”)終止合作開發北京市豐台區張儀村路東側棚户區改造項目(以下簡稱“張儀村棚改項目”)。
公司與集團公司終止合作開發張儀村項目後,集團公司收回對興潤公司的管理權,公司完全退出興潤公司,不再參與興潤公司經營管理及項目開發建設。公司累計向張儀村棚改項目投入的資金約3700萬元,由集團公司一次性償還。截止目前,張儀村棚改項目已取得立項批覆,完成了徵收服務單位選定、入户調查、結果公示、方案報批等工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.